BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21306768)

  • 1. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
    Lu RM; Chang YL; Chen MS; Wu HC
    Biomaterials; 2011 Apr; 32(12):3265-74. PubMed ID: 21306768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.
    He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH
    Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.
    Chen Y; Huang K; Li X; Lin X; Zhu Z; Wu Y
    Cancer Immunol Immunother; 2010 Jun; 59(6):933-42. PubMed ID: 20224978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
    Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.
    Winthrop MD; DeNardo SJ; Albrecht H; Mirick GR; Kroger LA; Lamborn KR; Venclovas C; Colvin ME; Burke PA; DeNardo GL
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redesigning of anti-c-Met single chain Fv antibody for the cytoplasmic folding and its structural analysis.
    Edwardraja S; Neelamegam R; Ramadoss V; Venkatesan S; Lee SG
    Biotechnol Bioeng; 2010 Jun; 106(3):367-75. PubMed ID: 20178123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
    Huo M; Zou A; Yao C; Zhang Y; Zhou J; Wang J; Zhu Q; Li J; Zhang Q
    Biomaterials; 2012 Sep; 33(27):6393-407. PubMed ID: 22704599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.
    Shmeeda H; Tzemach D; Mak L; Gabizon A
    J Control Release; 2009 Jun; 136(2):155-60. PubMed ID: 19331844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes.
    Rothdiener M; Beuttler J; Messerschmidt SK; Kontermann RE
    Methods Mol Biol; 2010; 624():295-308. PubMed ID: 20217604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of single-chain variable fragment antibody against c-Met in the cytoplasm of Escherichia coli.
    Heo MA; Kim SH; Kim SY; Kim YJ; Chung J; Oh MK; Lee SG
    Protein Expr Purif; 2006 May; 47(1):203-9. PubMed ID: 16414274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
    Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
    Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B; Xia S; Abounader R; Laterra J
    Clin Cancer Res; 2005 Jun; 11(12):4479-86. PubMed ID: 15958633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
    Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; MonteriĆ¹ G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
    BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles.
    Li W; Zhao H; Qian W; Li H; Zhang L; Ye Z; Zhang G; Xia M; Li J; Gao J; Li B; Kou G; Dai J; Wang H; Guo Y
    Biomaterials; 2012 Jul; 33(21):5349-62. PubMed ID: 22542611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles.
    Wang J; Tao X; Zhang Y; Wei D; Ren Y
    Biomaterials; 2010 May; 31(15):4426-33. PubMed ID: 20188412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.